Gossamer Bio, Inc. — Director's Dealing 2021

Jul 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2021-06-30

Reporting Person: Carter Laura (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-30	Common Stock	A	25000	—	Acquired	97683	Direct

Footnotes

F1: Represents a restricted stock unit award, which will vest on the first anniversary of the grant date in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on such vesting date.